Scientists seek COVID-19 origin nearly 2 years into pandemic

Nearly two years into the COVID-19 pandemic, the origin of the virus tormenting the world remains shrouded in mystery.

Google, Ford, other companies delay return-to-work plans amid omicron cases

Google and Ford are among those once again delaying their return-to-office plans, while other businesses whose workers are already back to the office are considering adding extra precautions like masks and COVID-19 testing.

Virginia health officials confirm first case of Omicron variant in the state

The Virginia Department of Health has announced the first confirmed case of the COVID-19 Omicron variant in a sample from an adult resident of the northwest region of the state.

New Zealand plans to implement lifetime ban on cigarettes for youth

New Zealand plans to end tobacco smoking by implementing a lifetime ban for those aged 14 or younger. The minimum age to buy cigarettes would keep rising year after year.

COVID-19 vaccines for kids: What if your child gets the wrong dose?

As efforts continue to vaccinate the nation’s younger population, some parents have reported their kids getting the wrong dose of the COVID-19 vaccine. While parents should remain diligent, health experts say it’s no cause for concern.

Senate rejects Biden administration's COVID-19 vaccine mandate for businesses

The Senate has narrowly approved a resolution to nullify the Biden administration’s requirement that businesses with 100 or more workers have their employees be vaccinated against the coronavirus or submit to weekly testing.

Virginia Department of Health denies request for school COVID-19 vaccine mandates

Virginia’s Department of Health will not be moving forward with a COVID-19 vaccine mandate for students, a decision that comes just one day after the D.C. Council voted to require the vaccine for eligible students. 

Medicago's plant-based COVID-19 vaccine showing promising trial results, company says

Medicago announced Tuesday that its two-dose vaccine was 71% effective at preventing COVID-19 infection in a large, late-stage study that included several variants including the delta variant.

Pfizer: COVID-19 booster offers protection against omicron in early study

Pfizer said its COVID-19 booster dose may protect against the new omicron variant, but the initial two doses appear significantly less effective.

DC Council votes on bill requiring students to get vaccinated against COVID-19

The DC Council voted on Tuesday on a bill to require DC students to get vaccinated once the COVID-19 vaccine for their age group is fully FDA approved.

COVID-related stress weighs heavily on Gen Z

Among Americans in Gen Z, 46% said the pandemic has made it harder to pursue their education or career goals.

WHO: Kids in 5-14 age group account for Europe's highest COVID-19 rates

The WHO's office for Europe said children in the 5 to 14 age group now account for the highest rates of reported COVID-19 infections in the region.

US to boost COVID-19 vaccine global distribution with $400M investment

“This money will speed efforts both to get shots in arms and to support vaccine manufacturing in low-and-middle-income countries,” USAID administrator Samantha Power announced Monday.